
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ALNY] Alnylam Pharmaceuticals Inc
Data updated 2025-May-30 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-May-30 Friday
Open | $292.45 | High | $306.00 +4.63% |
---|---|---|---|
Close | $304.56 | Low | $287.20 -1.80% |
Volume | 3.12 Million 1.20x | Volatility | 6.55% |
Change |
+$11.66
+3.98%
|
Streak | ↑ 2 days +6.65% |
20d SMA | $279.52 +9.0% | 50d SMA | $262.69 +15.9% | 100d SMA | $258.99 +17.6% | 200d SMA | $261.68 +16.4% |
RSI | 68 | MACD | 1.27 | ADX | 23.6 | Stochastic Oscillator | 87.3 83.9 |
CCI | 113.7 | ATR | 11.2 | OBV | 107 Million | Chaikin A/D | 77.6 Million |
Market Cap | 19.1 B | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 10.3 | Price/Book (mrq) | EV/Revenue (ttm) | 9.82 | EV/EBITDA (ttm) | -83.4 | |
% Held by Insiders | 0.40% | % Held by Institutions | 95.08% | Shares Short | 2.69 M | Shares Short (prior month) | 3.99 M |
Short Ratio | 2.1 | Short % of Outstanding | 2.14% | Short % of Float | 2.14% | Shares Short Change (mom) | -32.6% |
Revenue/Share (ttm) | $14.64 | Profit Margin (ttm) | -24.08% | Operating Margin (ttm) | -26.47% | EBITDA (ttm) | -228 M |
Diluted EPS (ttm) | $-3.52 | Current Ratio (mrq) | 3.08 | Return on Assets (ttm) | -4.78% | Return on Equity (ttm) | |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 31.20% | Operating Cash Flow (ttm) | 104 M | Free Cash Flow (ttm) | 147 M | |
Choose view type
Daily Performance for Alnylam Pharmaceuticals Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Alnylam Pharmaceuticals Inc up to close of 2025-May-30 at $304.56
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+5.38%
|
-0.5%
|
+7.2%
|
7.7%
|
+4.1%
|
+3.4%
|
1.20x
|
02 Trailing 10-days
|
|
+7.47%
|
-0.5%
|
+8.5%
|
9.1%
|
+4.5%
|
+5.2%
|
1.01x
|
03 Trailing 20-days
|
|
+19.37%
|
-0.5%
|
+23.8%
|
24.4%
|
+9.0%
|
+8.5%
|
0.95x
|
04 Trailing 30-days
|
|
+32.13%
|
-0.5%
|
+33.4%
|
34.0%
|
+13.3%
|
+11.0%
|
0.89x
|
05 Trailing 50-days
|
|
+20.17%
|
-0.5%
|
+47.9%
|
48.6%
|
+15.9%
|
+13.8%
|
1.22x
|
06 Trailing 100-days
|
|
+30.00%
|
-0.5%
|
+47.9%
|
48.6%
|
+17.6%
|
+16.6%
|
1.09x
|
07 Trailing 200-days
|
|
+12.72%
|
-0.5%
|
+47.9%
|
48.6%
|
+16.4%
|
+21.2%
|
0.91x
|
08 Month-to-date
|
|
+15.70%
|
-0.5%
|
+23.8%
|
24.4%
|
|
|
|
09 Quarter-to-date
|
|
+12.79%
|
-0.5%
|
+47.9%
|
48.6%
|
|
|
|
10 Year-to-date
|
|
+29.43%
|
-0.5%
|
+47.9%
|
48.6%
|
|
|
|
11 Trailing 52-weeks
|
|
+103.00%
|
-0.5%
|
+106.8%
|
107.8%
|
|
|
|
3-month Performance Benchmarks for Alnylam Pharmaceuticals Inc:
Related to Alnylam Pharmaceuticals Inc
Information for Alnylam Pharmaceuticals Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-30 on Google
SEC Reports : Quarterly reports around 2025-May-30 on SEC Edgar
Compare Alnylam Pharmaceuticals Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Alnylam Pharmaceuticals Inc
Industry : Biotechnology industry performance which includes Alnylam Pharmaceuticals Inc